PMID: 37296162
The only current exceptions are Rybelsus , an oral pill for type 2 diabetes, and, recently in 2026, Wegovy the first oral GLP-1 drug available for weight loss
The mitochondrial NAD + pool is relatively distinct from that of the rest of the cell
SVCT2 is preferentially expressed in specific tissues, such as the brain, adrenal and pituitary glands, lymphoid tissue, muscle, and bone (Tsukaguchi et al., 1999)
Based on results from the SURMOUNT-OSA trial, investigating tirzepatide in OSA patients with obesity, Eli Lilly submitted a supplemental new drug application to the FDA in June seeking approval for OSA
The effects of weight cycling on health and systemic metabolism are not thoroughly defined